INDUSTRY OVERVIEW
The Carrier Screening is Growing at 15.50% and is expected to reach 9.7Billion by 2032. Below mentioned are some of the dynamics shaping the Carrier Screening.Carrier Screening Market Size in (USD Billion) CAGR Growth Rate 15.50%
| Study Period | 2020-2032 |
| Market Size (2024): | 3.1Billion |
| Market Size (2032): | 9.7Billion |
| CAGR (2024 - 2032): | 15.50% |
| Fastest Growing Region | Asia-Pacific |
| Dominating Region | North America |
www.htfmarketinsights.com
Carrier screening tests individuals or couples to determine if they carry genes for inherited conditions that could be passed on to offspring. These screenings are especially useful for prospective parents planning to have children, particularly when there’s a family history or ethnic predisposition to certain conditions. Expanded carrier screening, which tests for a wide range of conditions irrespective of ethnicity, is gaining traction due to the decreasing cost of genetic sequencing and increased awareness. Carrier screening can inform decisions around IVF, prenatal care, and family planning, helping reduce the incidence of genetic diseases in newborns.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Rise In Prenatal Testing Demand
- Awareness Of Inherited Conditions
- Decline In Sequencing Costs
- Emphasis On Preventive Healthcare
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- Cultural & Ethical Sensitivities
- Data Interpretation Complexity
- Limited Coverage By Insurers
- Patient Education Gaps
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Expanded panels for multiple conditions
- Population-wide screening models
- Integration into routine care
- Home-based sample kits
Market Opportunities:
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Partnerships With OB/GYN Networks
- AI-driven Interpretation Tools
- Telehealth Integration
- Genetic Literacy Initiatives
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- Expanded Carrier Screening
- Targeted Panels
- Ethnicity-Based
- Pan-Ethnic
Carrier Screening Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Preconception testing
- IVF planning
- Prenatal screening
- Family planning
- Genetic counseling
Carrier Screening Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Asia-Pacific is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
Asia-Pacific
Dominating Region
North America
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- Natera
- Invitae
- Myriad Genetics
- Fulgent Genetics
- Labcorp
- Quest Diagnostics
- Thermo Fisher
- Gene by Gene
- Sema4
- Illumina
- BGI Genomics
- Baylor Genetics
- CooperGenomics
- Eurofins
- GenPath
- Ambry Genetics
- Centogene
- MedGenome
- 1Gene
- Orchid Health
Carrier Screening Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2024 |
|
Based Year Market Size (2023) |
3.1Billion |
|
Historical Period |
2020 to 2024 |
|
CAGR (2024 to 2032) |
15.50% |
|
Forecast Period |
2024 to 2032 |
|
Forecasted Period Market Size (2032) |
9.7Billion |
|
Scope of the Report |
Segmentation by Type Expanded Carrier Screening,Targeted Panels,Ethnicity-Based,Pan-Ethnic, Segmentation by Application Preconception testing,IVF planning,Prenatal screening,Family planning,Genetic counseling, Sales Channel |
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
Natera,Invitae,Myriad Genetics,Fulgent Genetics,Labcorp,Quest Diagnostics,Thermo Fisher,Gene by Gene,Sema4,Illumina,BGI Genomics,Baylor Genetics,CooperGenomics,Eurofins,GenPath,Ambry Genetics,Centogene,MedGenome,1Gene,Orchid Health |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Carrier Screening - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Carrier Screening Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Carrier Screening Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Carrier Screening Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Rise in prenatal testing demand
- 3.1.2 Awareness of inherited conditions
- 3.1.3 Decline in sequencing costs
- 3.1.4 Emphasis on preventive healthcare
-
3.2 Available Opportunities
- 3.2.1 Partnerships with OB/GYN networks
- 3.2.2 AI-driven interpretation tools
- 3.2.3 Telehealth integration
- 3.2.4 Genet
-
3.3 Influencing Trends
- 3.3.1 Expanded panels for multiple conditions
- 3.3.2 Population-wide screening models
- 3.3.3 Integration into rou
-
3.4 Challenges
- 3.4.1 Cultural & ethical sensitivities
- 3.4.2 Data interpretation complexity
- 3.4.3 Limited coverage by insurers
- 3.4.4
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Carrier Screening Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Carrier Screening Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Carrier Screening : Competition Benchmarking & Performance Evaluation
- 5.1 Global Carrier Screening Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Carrier Screening Revenue 2024
- 5.3 Global Carrier Screening Sales Volume by Manufacturers (2024)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 Strategic Group Analysis
- 5.6 5C’s Analysis
Chapter 6: Global Carrier Screening Market: Company Profiles
- 6.1 Natera
- 6.1.1 Natera Company Overview
- 6.1.2 Natera Product/Service Portfolio & Specifications
- 6.1.3 Natera Key Financial Metrics
- 6.1.4 Natera SWOT Analysis
- 6.1.5 Natera Development Activities
- 6.2 Invitae
- 6.3 Myriad Genetics
- 6.4 Fulgent Genetics
- 6.5 Labcorp
- 6.6 Quest Diagnostics
- 6.7 Thermo Fisher
- 6.8 Gene By Gene
- 6.9 Sema4
- 6.10 Illumina
- 6.11 BGI Genomics
- 6.12 Baylor Genetics
- 6.13 CooperGenomics
- 6.14 Eurofins
- 6.15 GenPath
- 6.16 Ambry Genetics
- 6.17 Centogene
- 6.18 MedGenome
- 6.19 1Gene
- 6.20 Orchid Health
- 6.21 Color Genomics
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Carrier Screening by Type & Application (2020-2032)
-
7.1 Global Carrier Screening Market Revenue Analysis (USD Million) by Type (2020-2024)
- 7.1.1 Expanded Carrier Screening
- 7.1.2 Targeted Panels
- 7.1.3 Ethnicity-Based
- 7.1.4 Pan-Ethnic
- 7.1.5 Whole-Exome
-
7.2 Global Carrier Screening Market Revenue Analysis (USD Million) by Application (2020-2024)
- 7.2.1 Preconception Testing
- 7.2.2 IVF Planning
- 7.2.3 Prenatal Screening
- 7.2.4 Family Planning
- 7.2.5 Genetic Counseling
- 7.3 Global Carrier Screening Market Revenue Analysis (USD Million) by Type (2024-2032)
- 7.4 Global Carrier Screening Market Revenue Analysis (USD Million) by Application (2024-2032)
Chapter 8 : North America Carrier Screening Market Breakdown by Country, Type & Application
- 8.1 North America Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 8.2.1 Expanded Carrier Screening
- 8.2.2 Targeted Panels
- 8.2.3 Ethnicity-Based
- 8.2.4 Pan-Ethnic
- 8.2.5 Whole-Exome
-
8.3 North America Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 8.3.1 Preconception Testing
- 8.3.2 IVF Planning
- 8.3.3 Prenatal Screening
- 8.3.4 Family Planning
- 8.3.5 Genetic Counseling
- 8.4 North America Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 8.5 North America Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 8.6 North America Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Carrier Screening Market Breakdown by Country, Type & Application
- 9.1 LATAM Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 9.2.1 Expanded Carrier Screening
- 9.2.2 Targeted Panels
- 9.2.3 Ethnicity-Based
- 9.2.4 Pan-Ethnic
- 9.2.5 Whole-Exome
-
9.3 LATAM Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 9.3.1 Preconception Testing
- 9.3.2 IVF Planning
- 9.3.3 Prenatal Screening
- 9.3.4 Family Planning
- 9.3.5 Genetic Counseling
- 9.4 LATAM Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 9.5 LATAM Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 9.6 LATAM Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 10 : West Europe Carrier Screening Market Breakdown by Country, Type & Application
- 10.1 West Europe Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 10.2.1 Expanded Carrier Screening
- 10.2.2 Targeted Panels
- 10.2.3 Ethnicity-Based
- 10.2.4 Pan-Ethnic
- 10.2.5 Whole-Exome
-
10.3 West Europe Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 10.3.1 Preconception Testing
- 10.3.2 IVF Planning
- 10.3.3 Prenatal Screening
- 10.3.4 Family Planning
- 10.3.5 Genetic Counseling
- 10.4 West Europe Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 10.5 West Europe Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 10.6 West Europe Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 11 : Central & Eastern Europe Carrier Screening Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 11.2.1 Expanded Carrier Screening
- 11.2.2 Targeted Panels
- 11.2.3 Ethnicity-Based
- 11.2.4 Pan-Ethnic
- 11.2.5 Whole-Exome
-
11.3 Central & Eastern Europe Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 11.3.1 Preconception Testing
- 11.3.2 IVF Planning
- 11.3.3 Prenatal Screening
- 11.3.4 Family Planning
- 11.3.5 Genetic Counseling
- 11.4 Central & Eastern Europe Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 11.5 Central & Eastern Europe Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 11.6 Central & Eastern Europe Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 12 : Northern Europe Carrier Screening Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 12.2.1 Expanded Carrier Screening
- 12.2.2 Targeted Panels
- 12.2.3 Ethnicity-Based
- 12.2.4 Pan-Ethnic
- 12.2.5 Whole-Exome
-
12.3 Northern Europe Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 12.3.1 Preconception Testing
- 12.3.2 IVF Planning
- 12.3.3 Prenatal Screening
- 12.3.4 Family Planning
- 12.3.5 Genetic Counseling
- 12.4 Northern Europe Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 12.5 Northern Europe Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 12.6 Northern Europe Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 13 : Southern Europe Carrier Screening Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 13.2.1 Expanded Carrier Screening
- 13.2.2 Targeted Panels
- 13.2.3 Ethnicity-Based
- 13.2.4 Pan-Ethnic
- 13.2.5 Whole-Exome
-
13.3 Southern Europe Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 13.3.1 Preconception Testing
- 13.3.2 IVF Planning
- 13.3.3 Prenatal Screening
- 13.3.4 Family Planning
- 13.3.5 Genetic Counseling
- 13.4 Southern Europe Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 13.5 Southern Europe Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 13.6 Southern Europe Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 14 : East Asia Carrier Screening Market Breakdown by Country, Type & Application
- 14.1 East Asia Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 14.2.1 Expanded Carrier Screening
- 14.2.2 Targeted Panels
- 14.2.3 Ethnicity-Based
- 14.2.4 Pan-Ethnic
- 14.2.5 Whole-Exome
-
14.3 East Asia Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 14.3.1 Preconception Testing
- 14.3.2 IVF Planning
- 14.3.3 Prenatal Screening
- 14.3.4 Family Planning
- 14.3.5 Genetic Counseling
- 14.4 East Asia Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 14.5 East Asia Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 14.6 East Asia Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 15 : Southeast Asia Carrier Screening Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 15.2.1 Expanded Carrier Screening
- 15.2.2 Targeted Panels
- 15.2.3 Ethnicity-Based
- 15.2.4 Pan-Ethnic
- 15.2.5 Whole-Exome
-
15.3 Southeast Asia Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 15.3.1 Preconception Testing
- 15.3.2 IVF Planning
- 15.3.3 Prenatal Screening
- 15.3.4 Family Planning
- 15.3.5 Genetic Counseling
- 15.4 Southeast Asia Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 15.5 Southeast Asia Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 15.6 Southeast Asia Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 16 : South Asia Carrier Screening Market Breakdown by Country, Type & Application
- 16.1 South Asia Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 16.2.1 Expanded Carrier Screening
- 16.2.2 Targeted Panels
- 16.2.3 Ethnicity-Based
- 16.2.4 Pan-Ethnic
- 16.2.5 Whole-Exome
-
16.3 South Asia Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 16.3.1 Preconception Testing
- 16.3.2 IVF Planning
- 16.3.3 Prenatal Screening
- 16.3.4 Family Planning
- 16.3.5 Genetic Counseling
- 16.4 South Asia Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 16.5 South Asia Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 16.6 South Asia Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 17 : Central Asia Carrier Screening Market Breakdown by Country, Type & Application
- 17.1 Central Asia Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 17.2.1 Expanded Carrier Screening
- 17.2.2 Targeted Panels
- 17.2.3 Ethnicity-Based
- 17.2.4 Pan-Ethnic
- 17.2.5 Whole-Exome
-
17.3 Central Asia Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 17.3.1 Preconception Testing
- 17.3.2 IVF Planning
- 17.3.3 Prenatal Screening
- 17.3.4 Family Planning
- 17.3.5 Genetic Counseling
- 17.4 Central Asia Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 17.5 Central Asia Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 17.6 Central Asia Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 18 : Oceania Carrier Screening Market Breakdown by Country, Type & Application
- 18.1 Oceania Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 18.2.1 Expanded Carrier Screening
- 18.2.2 Targeted Panels
- 18.2.3 Ethnicity-Based
- 18.2.4 Pan-Ethnic
- 18.2.5 Whole-Exome
-
18.3 Oceania Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 18.3.1 Preconception Testing
- 18.3.2 IVF Planning
- 18.3.3 Prenatal Screening
- 18.3.4 Family Planning
- 18.3.5 Genetic Counseling
- 18.4 Oceania Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 18.5 Oceania Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 18.6 Oceania Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 19 : MEA Carrier Screening Market Breakdown by Country, Type & Application
- 19.1 MEA Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2020-2024]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2020-2024]
- 19.2.1 Expanded Carrier Screening
- 19.2.2 Targeted Panels
- 19.2.3 Ethnicity-Based
- 19.2.4 Pan-Ethnic
- 19.2.5 Whole-Exome
-
19.3 MEA Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2020-2024]
- 19.3.1 Preconception Testing
- 19.3.2 IVF Planning
- 19.3.3 Prenatal Screening
- 19.3.4 Family Planning
- 19.3.5 Genetic Counseling
- 19.4 MEA Carrier Screening Market by Country (USD Million) & Sales Volume (Units) [2025-2032]
- 19.5 MEA Carrier Screening Market by Type (USD Million) & Sales Volume (Units) [2025-2032]
- 19.6 MEA Carrier Screening Market by Application (USD Million) & Sales Volume (Units) [2025-2032]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Carrier Screening market is estimated to derive a market size of 9.7 Billion by 2032.
The Carrier Screening Market is predicted to grow at a CAGR of 15.50%.
The changing dynamics and trends such as Expanded Panels For Multiple Conditions,Population-wide Screening Models,Integration Into Routine Care,Home-based Sample Kits,Genetic Counseling Services are seen as major Game Changer in Global Carrier Screening Market.
The leaders in the Global Carrier Screening Market such as Natera,Invitae,Myriad Genetics,Fulgent Genetics,Labcorp,Quest Diagnostics,Thermo Fisher,Gene by Gene,Sema4,Illumina,BGI Genomics,Baylor Genetics,CooperGenomics,Eurofins,GenPath,Ambry Genetics,Centogene,MedGenome,1Gene,Orchid Health,Color Genomics are targeting innovative and differentiated growth drivers some of them are Rise In Prenatal Testing Demand,Awareness Of Inherited Conditions,Decline In Sequencing Costs,Emphasis On Preventive Healthcare,Expansion Of Newborn Screening Programs
As Industry players prepare to scale up, Carrier Screening Market sees major concern such as Cultural & Ethical Sensitivities,Data Interpretation Complexity,Limited Coverage By Insurers,Patient Education Gaps,Regulatory Differences By Region.
Some of the opportunities that Analyst at HTF MI have identified in Carrier Screening Market are:
- Partnerships With OB/GYN Networks
- AI-driven Interpretation Tools
- Telehealth Integration
- Genetic Literacy Initiatives
- Expansion In Underserved Regions
Carrier Screening Market identifies market share by players along with the concentration rate using CR4, CR8 Index to determine leading and emerging competitive players such as Natera,Invitae,Myriad Genetics,Fulgent Genetics,Labcorp,Quest Diagnostics,Thermo Fisher,Gene by Gene,Sema4,Illumina,BGI Genomics,Baylor Genetics,CooperGenomics,Eurofins,GenPath,Ambry Genetics,Centogene,MedGenome,1Gene,Orchid Health,Color Genomics.
The Global Carrier Screening Market Study is Broken down by applications such as Preconception testing,IVF planning,Prenatal screening,Family planning,Genetic counseling.
The Global Carrier Screening Market Study is segmented by Expanded Carrier Screening,Targeted Panels,Ethnicity-Based,Pan-Ethnic,Whole-Exome.
The Global Carrier Screening Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2020 - Base year: 2024. Forecast period**: 2025 to 2032 [** unless otherwise stated]
Carrier screening tests individuals or couples to determine if they carry genes for inherited conditions that could be passed on to offspring. These screenings are especially useful for prospective parents planning to have children, particularly when there’s a family history or ethnic predisposition to certain conditions. Expanded carrier screening, which tests for a wide range of conditions irrespective of ethnicity, is gaining traction due to the decreasing cost of genetic sequencing and increased awareness. Carrier screening can inform decisions around IVF, prenatal care, and family planning, helping reduce the incidence of genetic diseases in newborns.
